By Padmanabhan Ananthan March 9 (Reuters) - U.S. drugmaker Pfizer said on Monday its experimental drug for a chronic skin disease met the main goal in a mid-stage study. Here are some details: * The ...

A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch relief and clear skin for many patients in a clinical trial, without the ...

(NYSE: PFE) today announced positive topline results from a Phase 2 study investigating tilrekimig (PF-07275315) in adults with moderate to severe atopic dermatitis. The study met its primary efficacy ...

FILE PHOTO: Eli Lilly logo is shown on one of the company's offices in San Diego, California, U.S., September 17, 2020. REUTERS/Mike Blake/File Photo (Reuters) -Eli Lilly announced on Friday safety ...

Turn Therapeutics (NASDAQ:TTRX) executives outlined the company’s focus on inflammatory skin disease and provided updates on ...

The intersection of eczema treatment and long-term health consequences has revealed an emerging crisis in skincare management. What begins as a standard treatment protocol often evolves into an ...

Children who develop eczema or other skin and respiratory allergies early in life face a higher risk of developing a food allergy, according to a recent study published in JAMA Pediatrics.

KUALA LUMPUR: What looks like a simple rash may not be so simple after all. Dermatologists in Malaysia are seeing more severe eczema cases, and one common thread keeps popping up: weeks or even months ...

Nara Smith is sharing more about her struggle with "severe eczema." The 23-year-old influencer continues to document her ongoing struggle with eczema over the years. On July 3, Nara shared a throwback ...

Nara Smith has been transparent about her struggles with her eczema over the years Nara Smith/Instagram; Daniele Venturelli/Getty Nara Smith has been transparent about her struggles with her eczema ...